A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae Solorzano Puerto, Antonio Gutiérrez Fernández, José Román, Eva Luna Del Castillo, Juan De Dios Roman, Juan Liébana Ureña, José Piédrola Angulo, Gonzalo We evaluated the activity of several antibiotics against 225 clinical isolates of Staphylococcus aureus and 252 isolates of Streptococcus agalactiae. Only tigecycline, glycopeptides, and linezolid were active against all the isolates of S. aureus, whereas the beta-lactams were also active against S. agalactiae. Tigecycline could be a good alternative to ampicillin in the treatment of group B Streptococcus infections in patients allergic to beta-lactam. 2024-04-09T08:17:56Z 2024-04-09T08:17:56Z 2007-08 info:eu-repo/semantics/article Sorlozano A, Gutierrez J, Roman E, de Dios Luna J, Roman J, Liebana J, Piedrola G. A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae. Diagn Microbiol Infect Dis. 2007 Aug;58(4):487-9. https://hdl.handle.net/10481/90523 10.1016/j.diagmicrobio.2007.02.009 eng http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional Elsevier